Hospice is concerned with ensuring the comfort of terminally ill people through the management of their pain and other symptoms. Given the importance of medication therapy to this objective, it is not surprising that pharmacists play a significant role in patient care. So too does the pharmacy benefit manager (PBM) for hospices.
A PBM’s primary function in the more significant healthcare industry is to handle claims and reimburse pharmacies for prescription distribution. In addition, they help manage prescription costs through formulary management and price negotiations with pharmaceutical companies.
Because hospices have particular needs, they typically rely on PBMs and other hospice-specialized pharmacy providers. SpectrumPS Pharmacia is descended from some of the earliest pharmacies and PBM providers to serve the hospice sector solely. Currently, it supports over 450 hospices representing over 90,000 people per day.
What is the function of a hospice PBM?
Each hospice PBM provides a distinct combination of services. They are divided into the following categories:
- Medication access
- Utilization management
- Pharmacological advice
- Regulatory compliance
- Process optimization
- Pharmaceutical Access
Hospice patients are usually treated at home but frequently rely on potent painkillers that cannot be found at a typical corner pharmacy. Additionally, their conditions can vary from hour to hour. In an instant, different drugs, dosages, or formulations may be necessary to ensure symptom relief.
In numerous ways, hospice PBMs enable drug access. Some hospice PBMs operate or contract with several “closed door” non-retail pharmacies nationwide to distribute drugs. However, maintaining adequate coverage in some places can be difficult. SpectrumPS provides a variety of models based on the usage of retail pharmacies and, frequently, SpectrumPS’s own mail order pharmacy that can meet next-day demands.
Drug costs are frequently the highest expense for hospices, after-labor, and facilities. Hospice PBMs can assist customers in developing tools and best practices for enhancing the quality and controlling costs. The clinical pharmacists at SpectrumPS utilize a range of devices, including:
- Custom formularies
- Evidence-based treatment procedures
- Protocols should be deprescribed
- Education of clinically appropriate and cost-effective alternatives
Reporting is another critical utilization management technique.SpectrumPS’s proprietary business intelligence platform provides trending data and visualization in real-time. Users can drill down to multiple levels (e.g., site and team) to uncover possibilities to improve care and control expenditures. Real-time warnings can identify future expense surges.
The goals and pharmacology of hospice care are distinct from curative health care. There are frequently insufficient data regarding the efficacy of some treatments for terminally sick patients. The dying phase provides complex difficulties with medicine metabolism. As their diseases worsen, patients may also require other administration routes.
In addition to providing fast access to pharmacological information and education, hospice PMBs should offer specialized clinical services tailored to hospice and palliative care. This includes providing evidence-based options for administering medicine in response to concerns about availability or to meet patient needs better.
SpectrumPS’s clinical support program includes strategic use management, educational opportunities, and pharmacists available 24 hours a day, seven days a week, to prescribe prescription therapy, boosting the interprofessional team. They help nurses and prescribers with numerous issues, such as:
- Complex cases
- Dose conversion
- Substitute drugs
- Regulatory Conformity
Read Also: Should We Have Universal Healthcare?
Hospices are heavily regulated, notably on medicine administration. Medicare’s Conditions of Participation, for instance, mandate drug utilization evaluations on admission and ongoing. These include all prescription and over-the-counter medications, herbal supplements, and alternative treatments that may interfere with pharmacological therapy. This is an opportunity for SpectrumPS clinical pharmacists to examine the prescription list attentively and identify therapies for which risks may outweigh benefits. They can be beneficial for analyzing over-the-counter drugs and dietary supplements with potential adverse effects or interactions.
Concerns over opioids have led to increasing regulation of banned medications in recent years. SpectrumPS assists hospices in enhancing compliance with existing and upcoming state and federal requirements by implementing suitable policies, procedures, and workflows. SpectrumPS can also examine overall usage to detect potential concern areas.
Hospice nurses cultivate intimate connections with patients and their carers to establish trust and promote the highest standard of care. Complicated or antiquated drug management workflows may distract them from this crucial work. Nurses may spend countless hours purchasing prescriptions, locating faxes, and reentering data into several databases. This affects not only patient treatment but also staff morale and retention negatively.
PBMs are third-party corporations that administer and manage prescription drug benefits on behalf of large employers and organizations, health insurers, Medicare Part D drug plans, pharmacies, and other payers. PBMs were created with convenience and cost-effectiveness in mind. Their objective was to aid in streamlining the medication claims process and containing and lowering prescription drug expenditures.
PBMs are regarded as pharmaceutical intermediaries. On behalf of their clients, they negotiate with medication manufacturers and distributors to reduce spending while processing prescription-related claims. According to The Commonwealth Fund, PBMs help insurers and pharmacies predict total drug prices. In an August 2018 Stat News piece, John Arnold notes that PBMs represent consumers from numerous large businesses and insurance, serving as enormous purchasing networks with significant purchasing leverage in the pharmaceutical industry. Ideally, PBMs use this purchasing power to reduce the total pharmaceutical cost and pass the savings to consumers.
PBMs are not merely intermediaries, however. PBMs are currently involved in:
- It is creating and revising formularies, i.e., the list of generic and brand-name prescription pharmaceuticals that insurance plans will cover.
- negotiating rebates with pharmaceutical manufacturers
- Local pharmacies dealt with for reimbursements, drug discounts, and delivery fees.
- They were determining which pharmacies included in a prescription drug plan network and managing distribution within networks.
- Conducting medication use evaluations
- Monitoring patient conformity
- Claims processing and payment
- Offering affordable mail-order pharmacy and specialty pharmaceutical services